Thursday, April 3, 2014
Publication and contact
generated from fibroblasts with one pluripotency factor and four small
Cell culture studies
suggest cardiomyocytes for use in pharmacological screening and regenerative
therapies could be generated with minimal genetic manipulation. In mouse
embryonic and tail tip fibroblasts, expression of the pluripotency
transcription factor Oct4
plus a combination of four small molecules led to beating cardiomyocytes via
a cardiac precursor state without transition through a pluripotent state. The
cardiomyocytes expressed cardiac- and ventricular-specific markers and
exhibited a cross-striated pattern and electrophysiological ventricular
characteristics. Next steps include isolating and expanding a cardiac cell
population and translating the approach to human cardiomyocytes.
Published online April 3, 2014
Patent application filed;
available for licensing
Wang, H. et al. Cell
Rep.; published online Feb. 20, 2014;
Contact: Sheng Ding, Gladstone Institute of Cardiovascular
Disease, San Francisco, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]